Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
PPhoenixBio Co.,Ltd. logo
6190TSE Growth

PhoenixBio Co.,Ltd.

フェニックスバイオ Yahoo Finance

Recent & upcoming events

Aug 14
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 26
Shareholder meeting 0:00
Shareholders' meeting
Venue: TKPガーデンシティPREMIUM広島駅北口（GRANODE広島3階）、広島県広島市東区二葉の里三丁目5番7号（受付開始 午後0時30分） Details
Add to Google Calendar
May 15
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Nov 13
Est.
Earnings 1:00 approx.
Q2 earnings
Add to Google Calendar
2027
Feb 12
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
May 14
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar
Aug 13
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar

KPI highlights

FY26
Revenue ¥1.57B YoY +1.6%
Operating income ¥83M margin 5.3%
Net income ¥125M YoY —
EPS ¥31 YoY —
P/E —
ROE 8.7% Equity ratio 70% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2027/03 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥1.61B +2.8%
Operating income ¥85M +2.7%
Net income ¥76M -39.3%
EPS ¥19 -38.7%

Quarterly fundamentals

Income & cash flow
Quarter FY22 Q4FY23 Q1FY23 Q2FY23 Q3FY23 Q4FY24 Q1
Revenue ¥525M¥464M¥439M¥443M¥447M¥387M
Operating income ¥98M¥44M¥7M¥-12M¥36M¥-20M
Net income ¥37M¥100M¥42M¥-15M¥-13M¥12M
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2026）

事業法人 39.5%個人 17.4%未開示 41.8%202120222023202420252026
事業法人国内機関海外機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

三和澱粉工業株式会社 31.3%三和澱粉工業株式会社森本　俊一 12.4%森本　俊一株式会社特殊免疫研究所 3.2%株式会社特殊免疫研究所株式会社叡拳 2.2%株式会社叡拳馬渡　祥二 1.9%馬渡　祥二島田　卓 1.7%島田　卓202120222023202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
三和澱粉工業株式会社 1,275,218 31.3% Yuho (EDINET)
森本 俊一 506,000 12.4% Yuho (EDINET)
株式会社特殊免疫研究所 129,000 3.2% Yuho (EDINET)
株式会社叡拳 88,000 2.2% Yuho (EDINET)
馬渡 祥二 75,600 1.9% Yuho (EDINET)
島田 卓 68,300 1.7% Yuho (EDINET)
株式会社関薬 58,300 1.4% Yuho (EDINET)
安田 信也 58,000 1.4% Yuho (EDINET)
中外テクノス株式会社 57,000 1.4% Yuho (EDINET)
J.P.Morgan Securities plc 52,018 1.3% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

7/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 5.7%
✓ Positive operating cash flow ¥69M
✓ ROA improved YoY -19.6% → 5.7%
✗ Operating CF exceeds net income (accrual quality) OCF ¥69M / net income ¥125M
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 59.1% → 70.2%
✓ Current ratio improved 3.03× → 4.40×
✗ No dilution (shares outstanding did not increase) 4,057,233 → 4,076,933
✓ Gross margin improved 72.5% → 76.7%
✓ Asset turnover improved 0.67× → 0.71×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio 70.2%
Current ratio 4.4×
Years of positive operating CF 4 of last 10 yrs
Payout ratio —
Latest fiscal year result Profit (net income ¥125M)

Performance history

Last 10 years
0億円5億円11億円16億円21億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 12.39.0212.313.110.113.221.217.215.415.7
Operating income 1.42-2.69-3.12-1.47-2.77-1.685.080.11-1.420.83
Ordinary income 1.33-2.67-2.80-1.25-2.24-1.285.110.44-1.551.31
Net income 1.28-2.71-2.97-4.16-2.38-3.884.930.26-4.491.25
Total assets 23.921.719.127.825.222.830.227.222.921.9
Equity 21.018.615.411.610.98.2815.118.013.715.5

Indicators & cash flow

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ¥44¥-93¥-102¥-142¥-74¥-117¥145¥7¥-111¥31
ROE 6.3%—————42.4%1.6%—8.7%
Operating CF 0.45-1.87-1.60-0.13-1.020.162.77-0.79-0.730.69
Investing CF 0.99-4.52-0.65-0.16-1.85-0.07-1.561.15-0.28-0.14
Financing CF 0.20-0.63-0.6511.5-1.60-0.350.87-2.45-1.28-0.88
FCF 1.44-6.39-2.24-0.28-2.870.091.210.36-1.010.55

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data